Pharma Industry News & Biotech Industry News from Medical News Today

Pharma Industry / Biotech Industry News

Pharma Industry / Biotech Industry News

The latest Pharma Industry News & Biotech Industry News articles published daily. Includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

Add this Pharma Industry rss news feed to your rss reader:

Latest News

Sucampo Pharmaceuticals Selected As A Finalist For Scrip Awards 2008 Pharma Company Of The Year - Small And Medium-Sized Enterprises Award

04 December 2008

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), a leading international biopharmaceutical company, today announced that it has been selected as a finalist for the Scrip Awards 2008 Pharma Company of the Year -- Small and Medium-Sized Enterprises Award...
[read article]

Evotec Announces Three-Year Drug Discovery Collaboration

04 December 2008

Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) today announced the start of a research collaboration with Novartis to identify and develop novel small molecule therapeutics. The collaboration will run for an initial period of three years...
[read article]

Cleveland Clinic Begins Public Disclosure Of Physician-Industry Relationships

04 December 2008

Cleveland Clinic this week began publishing on its Web site complete disclosures of physicians' and researchers' business relationships and financial ties, the New York Times reports...
[read article]

Pharma Industry / Biotech Industry News Articles Archive - Page 1

04 December 2008

Drug Marketing Techniques May Be Risking Patient Safety, British Medical Journal

Bionovo Announces Development Plans For Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings

Isis Announces That OGX-011 Has Shown Overall Survival Advantage In Prostate Cancer Compared To Standard Therapy In A Randomized Phase 2 Study

03 December 2008

'Intelligent' Materials To Revolutionise Surgical Implants - Nanotechnology Will Provide Superior Implants For Orthopaedic Patients

U.S. Naval Medical Research Center Resubmits IND Application For Proposed 'Op RESUS' Clinical Trial In Trauma Patients In The Battlefield Setting

Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint In A Phase II Clinical Trial In Patients With Xerostomia

New Sucrets(R) ICE Cools Sore Throat Pain

Heart Drugs: Brand Names No Better Than Generics, Study

02 December 2008

New Citeline Analysis Finds Substantial Disparity In The Number Of Ongoing Clinical Trials For The Top 20 Biotech Companies

USA Today Examines No-Cost Prescription Drug Samples

S*BIO Advances JAK2 Inhibitor SB1518 Into Phase 1/2 Clinical Trial In Australia For The Treatment Of Chronic Idiopathic Myelofibrosis

TorreyPines' NGX426, An Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints In Reducing Capsaicin Induced Pain In Healthy Subjects

GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials To Begin In North And South America

Vical Receives Milestone Payment From Merck & Co., Inc. Triggered By Planned Initiation Of Investigational Cancer DNA Vaccine Trial

FDA Approves Duramed's Synthetic Conjugated Estrogens A Vaginal Cream

ViroPharma Submits Supplemental Biologics License Application For Cinryze(TM) To Treat Acute Attacks Of Hereditary Angioedema

109 Medicines And Vaccines Now In Development For HIV/AIDS

01 December 2008

BGMA Welcomes The Preliminary Report Of The European Commission Sectoral Inquiry Into The Pharmaceutical Industry, UK

Pharmaceuticals Sector Interim Report: European Commission Attacks Practices That Prevent Competition From Generic Drugs

Antitrust: Preliminary Report On Pharmaceutical Sector Inquiry Highlights Cost Of Pharma Companies' Delaying Tactics - European Commission

Cranfield Health Provides The Missing Link, UK

29 November 2008

Electric Fields Clean Up Bioreactors

Lilly Withdraws Application For Additional U.S. Indication For Cymbalta(R) For Chronic Pain

28 November 2008

Nplate(TM) (Romiplostim) Receives Positive Opinion For Marketing Authorisation In The European Union

Schering Plough Reports Preladenant Meets Primary Endpoint In Phase II Dose-Finding Trial For Parkinson's Disease

New Phase III Study Of Avastin In Advanced Breast Cancer Meets Its Primary Endpoint Of Increasing The Time Patients Live

Misleading Media Coverage Of Medicine

Compugen And Merck Serono To Collaborate On Novel Peptide For The Treatment Of Inflammatory Diseases

27 November 2008

Enrollment In Provectus' Phase 2 Melanoma Clinical Trial Reaches Halfway Point

Deadline Approaches For Paper And Panel Submissions For 2009 World Congress On Industrial Biotechnology And Bioprocessing

Teva Announces Agreement On Generic Pulmicort Respules(R) Patent Challenge

Avalon Pharmaceuticals Receives NASDAQ Deficiency Notice

International Society For Pharmaceutical Engineering Sponsors Special PQLI Session At IFPAC's Annual Meeting

Ceregene Announces Clinical Data From Phase 2 Clinical Trial Of CERE-120 For Parkinson's Disease

FDA Issues Complete Response Letter For Ceftobiprole For Treatment Of Complicated Skin Infections

Genentech Issues Dear Healthcare Provider Letter Regarding A 2nd Case Of PML In A Raptiva Patient

Sandoz Receives Positive EU Opinion For Biosimilar Filgrastim

26 November 2008

Pharmacyclics Announces Completion Of Phase 1 Clinical Trial Of Factor VIIa Inhibitor PCI-27483

25 November 2008

HIV - Avexa Completes Recruitment For First Component Of ATC Phase III Trial

Exelixis And Bristol-Myers Squibb To Co-Develop XL413, A Selective Cdc7 Inhibitor

OrBec(R) Receives Orphan Drug Designation In Australia For The Treatment Of Gastrointestinal Graft-Versus-Host-Disease

Chorea Associated With Huntington's Disease Ovation - Nationwide Availability Of Xenazine (tetrabenazine) Tablets In U.S.

Medicaid Paid Nearly $198M For More Than 100 Unapproved Drugs From 2004-2007, According To AP Analysis

BIO-Europe 2008 Sets New Record For Partnering Productivity

Harvard Medical School And Cellectricon Collaborate Around Whole-Genome RNAi Screening Technology - Cellaxess(R)HT

New Study Finds Publication Bias Among Trials Submitted To FDA

Regulation Award At National Business Awards

Schering Plough Provides Update On Boceprevir Clinical Development And Introduces Potent Next Generation Oral HCV Protease Inhibitor

Schering Plough Reports Preladenant Meets Primary Endpoint In Phase II Dose-Finding Trial For Parkinson's Disease

Schering-Plough Unveils Top-Line Study Results For SAPHRIS(TM) (asenapine) Demonstrating Efficacy In Long-Term Schizophrenia Relapse Prevention

Medarex Announces Initiation Of Phase 1b Clinical Development Program With MDX-1106 For The Treatment Of Cancer

23 November 2008

UC San Diego Announces Collaboration With Johnson & Johnson Pharmaceutical Research & Development

Novel Antidepressant Valdoxan(R), Receives EMEA CHMP Positive Opinion For Major Depressive Episodes

Informa Launches New ROI Tracking Tool And Crm Solution For Pharma Brand Managers

FDA To Share Perspective On Polymorphic Forms In Abbreviated New Drug Applications - 6th Annual IQPC Polymorphism & Crystallisation Conference

Investment In Medical Research Provides Excellent Financial And Social Benefits, New Study

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions


News Archive [link] Web Wikipedia Medical Dictionary [link]